Evidence map›Paper›PMID 39039694›Full record

SynthesisCancer biology & therapy2024

Association between the

Fabíola Silva Alves-Hanna, Felipe Rodolfo Pereira Silva, Daniele Sá Pereira, Alessandro Luiz Araújo Bentes Leal, Fábio Magalhães-Gama, Allyson Guimarães Costa

Abstract readMeta-AnalysisReview
In one paragraph

Synthesis in Cancer biology & therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fabíola Silva Alves-HannaDiretoria de Ensino e Pesquisa, Fundação Hospitalar de Hematologia e Hemoterapia do Amazonas (HEMOAM), Manaus, Brazil.ORCID 0000-0002-1582-2969
Felipe Rodolfo Pereira SilvaPrograma de Pós-Graduação em Imunologia Básica e Aplicada, Universidade Federal do Amazonas (UFAM), Manaus, Brazil.
Daniele Sá PereiraDiretoria de Ensino e Pesquisa, Fundação Hospitalar de Hematologia e Hemoterapia do Amazonas (HEMOAM), Manaus, Brazil.ORCID 0000-0003-2129-6683
Alessandro Luiz Araújo Bentes LealPrograma de Pós-Graduação em Ciências Biomédicas, Universidade Federal do Delta do Parnaíba (UFDPar), Parnaíba, Brazil.
Fábio Magalhães-GamaPrograma de Pós-Graduação em Ciências da Saúde, Instituto René Rachou - Fundação, Oswaldo Cruz (FIOCRUZ) Minas, Belo Horizonte, Brazil.ORCID 0000-0003-1373-0953
Allyson Guimarães CostaDiretoria de Ensino e Pesquisa, Fundação Hospitalar de Hematologia e Hemoterapia do Amazonas (HEMOAM), Manaus, Brazil.ORCID 0000-0002-7312-6822

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The relationship between the

Indexed as

Genetic Predisposition to DiseaseHematologic NeoplasmsInterleukin-1betaPolymorphism, Single NucleotideCase-Control StudiesHumansRisk FactorsInterleukin-1betagenetic variationshematologic malignanciesInterleukin-1meta-analysispolymorphism

Identifiers

PMID39039694
PMCPMC11268255

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.